Community Solutions to Adolescent Research Consent - Minor Consent for Biomedical HIV Research
Launched by INDIANA UNIVERSITY · May 8, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria - Deliberants must:
- • Complete the screening survey;
- • Be at least 14 years of age;
- • Speak and understand English; and,
- • Be able to commit to attend all virtual deliberation sessions in their entirety.
- * Be one of the following:
- • 14-21years old
- • Have an adolescent who lives with you
- • Closely involved with an adolescent on a regular basis (e.g. grandparent, adult sibling)
- • Work for an organization or program that is invested in the wellbeing of adolescents in your community (e.g. social worker, high school teacher, nonprofit work)
- • Part of an organization or program that is invested in the wellbeing of adolescents in your community (e.g. mentor, volunteer, church youth group)
- Exclusion Criteria:
- • Those who are obviously inebriated or high at the time of screening, the deliberation event, or the pre-/post-event interviews;
- • Those who reside in a home with another eligible participant
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Patients applied
Trial Officials
Amy Knopf, PhD RN MPH
Principal Investigator
Indiana University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials